{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:27:27Z","timestamp":1773145647624,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,9,22]],"date-time":"2006-09-22T00:00:00Z","timestamp":1158883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s00259-006-0234-z","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T23:50:52Z","timestamp":1159919452000},"page":"228-236","source":"Crossref","is-referenced-by-count":24,"title":["Change in the intrathyroidal kinetics of radioiodine under continued and discontinued antithyroid medication in Graves\u2019 disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Simone","family":"Dunkelmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubertus","family":"Kuenstner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Groth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Schuemichen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,22]]},"reference":[{"key":"234_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0038-1625922","volume":"40","author":"V Urbannek","year":"2001","unstructured":"Urbannek V, Voth E, Moka D, Schicha H. Radioiodine therapy of Graves\u2019 disease dosimetric comparison of different strategies concerning antithyroid drugs. Nuklearmedizin 2001;40:111\u20135.","journal-title":"Nuklearmedizin"},{"issue":"12","key":"234_CR2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1089\/thy.1999.9.1181","volume":"9","author":"O Sabri","year":"1999","unstructured":"Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostwald E, Buell U. Radioiodine therapy in Graves\u2019 disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Thyroid 1999;9(12):1181\u20138.","journal-title":"Thyroid"},{"issue":"4","key":"234_CR3","first-page":"1229","volume":"84","author":"O Sabri","year":"1999","unstructured":"Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K. Success rate of radioiodine therapy in Graves\u2019 disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 1999;84(4):1229\u201333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"234_CR4","first-page":"3488","volume":"86","author":"VA Andrade","year":"2001","unstructured":"Andrade VA, Gross JL, Maia AL. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves\u2019 hyperthyroidism: one year follow-up of a prospective, randomized study. J Clin Endocrinol Metab 2001;86(8):3488\u201393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"234_CR5","first-page":"3016","volume":"86","author":"HB Burch","year":"2001","unstructured":"Burch HB, Solomon BL, Cooper DS, Perguson P, Walpert N, Howard R. The effect of antithyroid drug pre-treatment on acute changes in thyroid hormone levels after 131I ablation for Graves\u2019 disease. J Clin Endocrinol Metab 2001;86(7):3016\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"234_CR6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.mnm.0000130242.29692.b2","volume":"25","author":"S Razvi","year":"2004","unstructured":"Razvi S, Basu A, Mclntyre EA, Wahid ST, Bartholomew PH, Weaver JU. Low failure rate of fixed administered activity of 400\u00a0MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: the Gateshead Protocol. Nucl Med Commun 2004;25(7):675\u201382.","journal-title":"Nucl Med Commun"},{"issue":"7","key":"234_CR7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00252995","volume":"13","author":"JM Connell","year":"1987","unstructured":"Connell JM, Hilditch TE, Robertson J, Coghill G, Alexander WD. Radioprotective action of carbimazole in radioiodine therapy for thyrotoxicosis\u2014influence of the drug on iodine kinetics. Eur J Nucl Med 1987;13(7):358\u201361.","journal-title":"Eur J Nucl Med"},{"key":"234_CR8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00259-006-0092-8","volume":"33","author":"MA Walter","year":"2006","unstructured":"Walter MA, Christ-Crain M, Schindler C, M\u00fcller-Brand J, M\u00fcller B. Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison. Eur J Nucl Med Mol Imaging 2006;33:730\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"234_CR9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1055\/s-2008-1070506","volume":"106","author":"J Brunn","year":"1981","unstructured":"Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. Volumetry of the lobe of the thyroid gland by means of realtime sonography. Dtsch Med Wochenschr 1981;106:1338\u201340.","journal-title":"Dtsch Med Wochenschr"},{"key":"234_CR10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1625320","volume":"44","author":"S Dunkelmann","year":"2005","unstructured":"Dunkelmann S, Neumann V, Staub U, Kuenstner H, Groth P, Sch\u00fcmichen C. Results of a risk-adapted and functional radioiodine therapy in Graves\u2019 disease. Nuklearmedizin 2005;44:238\u201342.","journal-title":"Nuklearmedizin"},{"key":"234_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1623910","volume":"43","author":"T Rink","year":"2004","unstructured":"Rink T, Bormuth FJ, Braun S, Zimny M, Schroth H-J. Concept and validation of a simple model of the intrathyroidal iodine kinetics. Nuklearmedizin 2004;43:21\u20135.","journal-title":"Nuklearmedizin"},{"issue":"3","key":"234_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1740-8261.2005.00040.x","volume":"46","author":"AJ Fischetti","year":"2005","unstructured":"Fischetti AJ, Drost WT, Dibartola SP, Chew DJ, Schenck PA, Meadows C. Effects of methimazole on thyroid gland uptake of 99mTc-pertechnetate in 19 hyperthyroid cats. Vet Radiol Ultrasound 2005;46(3):267\u201372.","journal-title":"Vet Radiol Ultrasound"},{"issue":"14","key":"234_CR13","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1073\/pnas.95.14.8251","volume":"95","author":"K Suzuki","year":"1998","unstructured":"Suzuki K, Lavaroni S, Mori A, Ohta M, Saito J, Pietrarelli M, et al. Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci U S A 1998;95(14):8251\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"234_CR14","first-page":"3331","volume":"82","author":"T Saito","year":"1997","unstructured":"Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, et al. Increased expression of the Na+\/I\u2212 symporter in cultured human thyroid cells exposed to thyrotropin and in Graves\u2019 thyroid tissue. J Clin Endocrinol Metab 1997;82(10):3331\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"234_CR15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1998.00570.x","volume":"49","author":"RA Ajjan","year":"1998","unstructured":"Ajjan RA, Kamaruddin NA, Crisp M, Watson PF, Weetmann AP. Regulation and tissue distribution of the human sodium iodide symporter gene. Clin Endocrinol (Oxf) 1998;49(4):517\u201323.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"234_CR16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/thy.1999.9.821","volume":"9","author":"C Spitzweg","year":"1999","unstructured":"Spitzweg C, Joba W, Morris JC, Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 1999;9(8):821\u20133.","journal-title":"Thyroid"},{"key":"234_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/joe.1.05643","volume":"184","author":"AC Ferreira","year":"2005","unstructured":"Ferreira AC, Lima LP, Araujo RL, Muller G, Rocha RP, Rosenthal D. Rapid regulation of thyroid sodium-iodide symporter by thyrotrophin and iodide. J Endocrinol 2005;184:69\u201376.","journal-title":"J Endocrinol"},{"issue":"3","key":"234_CR18","first-page":"519","volume":"47","author":"J Clerc","year":"2001","unstructured":"Clerc J, Kahn E, Fragu P. SIMS evidence that carbimazole enhances spatial heterogeneity of thyroid iodine storage and targeting in a woman with Graves\u2019 disease. Cell Mol Biol (Noisy-le-grand) 2001;47(3):519\u201327.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"234_CR19","first-page":"33","volume":"44","author":"MA Walter","year":"2005","unstructured":"Walter MA, Christ-Crain M, M\u00fcller B, M\u00fcller-Brand J. Radioiodine uptake and thyroid hormone levels on or off simultaneous carbimazole medication. Nuklearmedizin 2005;44:33\u20136.","journal-title":"Nuklearmedizin"},{"issue":"6","key":"234_CR20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2265.1979.tb02122.x","volume":"10","author":"T Nakashima","year":"1979","unstructured":"Nakashima T, Taurog A. Rapid conversion of carbimazole to methimazole in serum: evidence for an enzymatic mechanism. Clin Endocrinol (Oxf) 1979;10(6):637\u201348.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"234_CR21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0038-1625295","volume":"41","author":"P Schneider","year":"2002","unstructured":"Schneider P, K\u00f6rber C, K\u00f6rber-Hafner N, H\u00e4nscheid H, Reiners C. Does an individual estimation of half-life improve the results of radioiodine therapy of Graves\u2019 disease? Nuklearmedizin 2002;41(6):240\u20134.","journal-title":"Nuklearmedizin"},{"key":"234_CR22","first-page":"1632","volume":"34","author":"A Bockisch","year":"1993","unstructured":"Bockisch A, Jarnitzky T, Derwanz R, Biersack HJ. Optimized dose planning of radioiodine therapy of benign thyroidal diseases. J Nucl Med 1993;34:1632\u20138.","journal-title":"J Nucl Med"},{"key":"234_CR23","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1210\/jc.2002-020580","volume":"87","author":"F Bogazzi","year":"2002","unstructured":"Bogazzi F, Bartalena L, Campomori A, Brogioni S, Traino C, De Martino F. Treatment with lithium prevents serum thyroid hormone increase after withdrawal and radioiodine therapy in patients with Graves\u2019 disease. J Clin Endocrinol Metab 2002;87:4490\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"234_CR24","first-page":"A103","volume":"44","author":"P Groth","year":"2005","unstructured":"Groth P, Dunkelmann S, Staub U, Sch\u00fcmichen C. Stunning der Schilddr\u00fcse\u2014ein Fr\u00fcheffekt der Iod-131-Therapie? Nuklearmedizin 2005;44:A103.","journal-title":"Nuklearmedizin"},{"issue":"2","key":"234_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/105072502753522365","volume":"12","author":"M Braga","year":"2002","unstructured":"Braga M, Walpert N, Burch HB, Solomon BL, Cooper DS. The effect of methimazole on cure rates after radioiodine treatment for Graves\u2019 hyperthyroidism: a randomized clinical trial. Thyroid 2002;12(2):135\u20139.","journal-title":"Thyroid"},{"issue":"4","key":"234_CR26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2265.1997.2741075.x","volume":"47","author":"LD Hancock","year":"1997","unstructured":"Hancock LD, Tuttle RM, Le Mar H, Bauman J, Patience T. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves\u2019 disease. Clin Endocrinol (Oxf) 1997;47(4):425\u201330.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"234_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jcem.83.2.4538","volume":"83","author":"RE Imseis","year":"1998","unstructured":"Imseis RE, Vanmiddelesworth L, Massie JD, Bush AJ, Vanmiddelesworth NR. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 1998;83:685\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"234_CR28","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1210\/jc.2004-0247","volume":"89","author":"SJ Bonnema","year":"2004","unstructured":"Bonnema SJ, Bennedbaek FN, Veje A, Marving J, Heged\u00fcs L. Propylthiouracil before 131I therapy of hyperthyroid disease: effect on cure rate evaluated by a randomised clinical trial. J Clin Endocrinol Metab 2004;89(9):4439\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"234_CR29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2265.2001.01239.x","volume":"54","author":"M Homsanit","year":"2001","unstructured":"Homsanit M, Sriussadaporn S, Vannasaeng S, Peerapatdit T, Nitiyanant W, Vichayanrat A. Efficacy of single daily dosage of methimazole vs. propylthioracil in the induction of euthyroidism. Clin Endocrinol 2001;54:385\u201390.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"234_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/thy.1995.5.7","volume":"5","author":"AW Kung","year":"1995","unstructured":"Kung AW, Yau CC, Cheng AC. The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism. Thyroid 1995;5(1):7\u201312.","journal-title":"Thyroid"},{"issue":"3","key":"234_CR31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2362.1995.tb01547.x","volume":"25","author":"H Peters","year":"1995","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Radioiodine therapy of Graves\u2019 hyperthyroidism: standard vs. calculated 131-iodine activity. Results from a prospective, randomised, multicentre study. Eur J Clin Invest 1995;25(3):186\u201393.","journal-title":"Eur J Clin Invest"},{"key":"234_CR32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1259\/0007-1285-38-445-72","volume":"38","author":"WR Greig","year":"1965","unstructured":"Greig WR, Crooks J, Macgregor AG, Mcinthosh JA. The radioprotective effect of methylthiouracil on the thyroid gland of the rat. Br J Radiol 1965;38:72\u20134.","journal-title":"Br J Radiol"},{"issue":"3","key":"234_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.2003.01850.x","volume":"59","author":"M Abalovich","year":"2003","unstructured":"Abalovich M, Llesuy S, Gutierrez S, Repetto M. Peripheral parameters of oxidative stress in Graves\u2019 disease: the effects of methimazole and 131 iodine treatments. Clin Endocrinol (Oxf) 2003;59(3):321\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"234_CR34","first-page":"1073","volume":"87","author":"EK Alexander","year":"2002","unstructured":"Alexander EK, Larsen PR. High dose of 131I-therapy for the treatment of hyperthyroidism caused by Graves\u2019 disease. J Clin Endocrinol Metab 2002;87(3):1073\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"234_CR35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF03348615","volume":"13","author":"C Marcocci","year":"1990","unstructured":"Marcocci C, Gianchechi D, Masini I, Golia F, Ceccarelli C, Bracci E, et al. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves\u2019 hyperthyroidism. J Endocrinol Invest 1990;13(6):513\u201320.","journal-title":"J Endocrinol Invest"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0234-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-006-0234-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0234-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:58:57Z","timestamp":1558699137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-006-0234-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,22]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1007\/s00259-006-0234-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,22]]}}}